ELEVATION ONCOLOGY INC (ELEV)
US28623U1016 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -45.70M | -95.08M | -32.04M | -17.27M | -5.88M | |||
| Depreciation Amortization | 39.00K | 30.00K | 20.00K | 20.00K | 0.00 | |||
| Change In Working Capital | -13.69M | 6.29M | 280.00K | 4.90M | 420.00K | |||
| Interest Paid | 3.16M | 980.00K | N/A | N/A | N/A | |||
| Other non cash items | 3.17M | 3.28M | 1.57M | 50.00K | 10.00K | |||
| OPERATING CASH FLOW | -56.18M | -85.48M | -30.17M | -12.30M | -5.45M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -90.00K | 0.00 | -70.00K | 0.00 | |||
| Other Investing Activity | 11.54M | -44.31M | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | 11.54M | -44.40M | 0.00 | -70.00K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 46.50M | 30.00M | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 1.47M | -20.00K | 97.06M | 90.20M | 7.27M | |||
| Other Financing Activity | 0.00 | -470.00K | -10.00K | -170.00K | -80.00K | |||
| FINANCING CASH FLOW | 47.98M | 29.51M | 97.05M | 90.03M | 7.19M | |||
| CHANGE IN CASH | 3.34M | -100.37M | 66.88M | 77.66M | 1.74M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -56.18M | -85.48M | -30.17M | -12.30M | -5.45M | |||
| Capital Expenditure | 0.00 | -90.00K | 0.00 | -70.00K | 0.00 | |||
| FREE CASH FLOW | -56.18M | -85.57M | -30.17M | -12.37M | -5.45M | |||
All data in USD